Thomas M. Gress

Active 1990–2025

125
Papers
21,143
Citations
83
h-index
118
i10-index

Citations

Citations per year for Thomas M. Gress1991: 2 citations1992: 1 citations1993: 4 citations1994: 4 citations1995: 9 citations1996: 15 citations1997: 26 citations1998: 32 citations1999: 40 citations2000: 51 citations2001: 63 citations2002: 74 citations2003: 96 citations2004: 99 citations2005: 116 citations2006: 95 citations2007: 138 citations2008: 137 citations2009: 128 citations2010: 174 citations2011: 162 citations2012: 165 citations2013: 159 citations2014: 221 citations2015: 220 citations2016: 196 citations2017: 208 citations2018: 172 citations2019: 635 citations2020: 664 citations2021: 698 citations2022: 562 citations2023: 484 citations2024: 690 citations2025: 348 citations2026: 13 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,220 citing papers, 24.2% of this breakdownChina: 1,302 citing papers, 14.2% of this breakdownGermany: 860 citing papers, 9.4% of this breakdownUnited Kingdom: 567 citing papers, 6.2% of this breakdownItaly: 458 citing papers, 5% of this breakdownJapan: 360 citing papers, 3.9% of this breakdownFrance: 335 citing papers, 3.6% of this breakdownNetherlands: 264 citing papers, 2.9% of this breakdownCanada: 241 citing papers, 2.6% of this breakdownAustralia: 226 citing papers, 2.4% of this breakdownSpain: 209 citing papers, 2.3% of this breakdownSweden: 174 citing papers, 1.9% of this breakdown
0%24.2%Other 21.4%

Fields

  • Medicine57.7%
  • Biochemistry, Genetics and Molecular Biology31.5%
  • Immunology and Microbiology3.5%
  • Neuroscience3.1%
  • Computer Science1.4%
  • Engineering1%
  • Other1.8%

Topics

  • Pancreatic and Hepatic Oncology Research10.4%
  • Neuroendocrine Tumor Research Advances4.8%
  • Pancreatitis Pathology and Treatment4.2%
  • Cancer Cells and Metastasis3.3%
  • Lung Cancer Research Studies2.8%
  • Epigenetics and DNA Methylation2.1%
  • Other72.4%

Coauthors

All papers

Open in search
  1. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 688

  2. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 625

  3. Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 2,499

  4. Microenvironmental Determinants of Pancreatic Cancer

    Authors: , , , , , , - Physiological Reviews 2020 cited by 350

  5. The Immune Microenvironment in Pancreatic Cancer

    Authors: , , , , , , , , , - International Journal of Molecular Sciences 2020 cited by 255

  6. IL-17A-producing CD8 + T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2023 cited by 79

  7. Stromal biology and therapy in pancreatic cancer: a changing paradigm

    Authors: , , , - Gut 2015 cited by 548

  8. Stromal biology and therapy in pancreatic cancer: ready for clinical translation?

    Authors: , , , , , , , - Gut 2018 cited by 369

  9. Chronic pancreatitis

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2017 cited by 447

  10. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco J. Bruno - Gastroenterology 2021 cited by 110

  11. Stromal biology and therapy in pancreatic cancer

    Authors: , , , , , , , , , , - Gut 2010 cited by 754

  12. Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival

    Authors: , , , , , , , , - Neuroendocrinology 2016 cited by 384

  13. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 137

  14. StellaTUM: current consensus and discussion on pancreatic stellate cell research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gut 2011 cited by 418

  15. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model

    Authors: , , , , , , , , , , , , , , , , - Cancer Immunology Research 2023 cited by 57

  16. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2012 cited by 582

  17. Epigenetic Regulation of Autophagy by the Methyltransferase G9a

    Authors: , , , , , , , , , , , , , - Molecular and Cellular Biology 2013 cited by 218

  18. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

    Authors: , , , , , , , , , , , , , , , , , , - Gut 2017 cited by 197

  19. Clinical Impact of Molecular Subtyping of Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , - Frontiers in Cell and Developmental Biology 2021 cited by 75

  20. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer

    Authors: , , , , , , - Gut 2016 cited by 129

  21. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Joachim Mössner, Niels Teich, Miklós Sahin‐Tóth - Nature Genetics 2007 cited by 435

  22. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.

    Authors: , , , , , , , - 2003 cited by 136

  23. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Hidalgo, Alfredo Carrato, Rita T. Lawlor, Francisco X. Real, Núria Malats - Cancer Epidemiology Biomarkers & Prevention 2020 cited by 79

  24. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

    Authors: , , , , , , , , , , , , , , , , , , , - Pancreatology 2020 cited by 103